Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Carboplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2017

A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC

Crandall, J. P., Tahari, A. K., Juergens, R. A., Brahmer, J. R., Rudin, C. M., Esposito, G., Subramaniam, D. S., Knopp, M. V., Hall, N. C., Gajwani, P., Leal, J. P., Lodge, M. A., Joo, H. O., Gabrielson, E. W., Shankar, L. K. & Wahl, R. L. Dec 1 2017 In : EJNMMI Research. 7, 1, 8

Research output: Research - peer-reviewArticle

Non-Small Cell Lung Carcinoma
Drug Therapy
Neoplasms
Therapeutics
Positron Emission Tomography Computed Tomography

Clinical mutational profiling of 1006 lung cancers by next generation sequencing

Illei, P. B., Belchis, D., Tseng, L. H., Nguyen, D., De Marchi, F., Haley, L., Riel, S., Beierl, K., Zheng, G., Brahmer, J. R., Askin, F. B., Gocke, C. D., Eshleman, J. R., Forde, P. M. & Lin, M. T. Jan 1 2017 In : Oncotarget. 8, 57, p. 96684-96696 13 p.

Research output: Research - peer-reviewArticle

Lung Neoplasms
Mutation
Neoplasms
Sequence Deletion
Missense Mutation

Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern

Kaunitz, G. J., Loss, M., Rizvi, H., Ravi, S., Cuda, J. D., Bleich, K. B., Esandrio, J., Sander, I., Le, D. T., Diaz, L. A., Brahmer, J. R., Drake, C. G., Hollmann, T. J., Lacouture, M. E., Hellmann, M. D., Lipson, E. J. & Taube, J. M. 2017 In : American Journal of Surgical Pathology. 41, 10, p. 1381-1389 9 p.

Research output: Research - peer-reviewArticle

Skin
Therapeutics
CD274 Antigen
Apoptosis Regulatory Proteins
Neoplasms

Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

Anagnostou, V. , Smith, K. N. , Forde, P. M. , Niknafs, N. , Bhattacharya, R. , White, J. , Zhang, T. , Adleff, V. , Phallen, J. , Wali, N. , Hruban, C. , Guthrie, V. B. , Rodgers, K. , Naidoo, J. , Kang, H. , Sharfman, W. , Georgiades, C. , Verde, F. , Illei, P. , Li, Q. K. & 9 others Gabrielson, E., Brock, M. V., Zahnow, C. A., Baylin, S. B., Scharpf, R. B., Brahmer, J. R., Karchin, R., Pardoll, D. M. & Velculescu, V. E. Mar 1 2017 In : Cancer Discovery. 7, 3, p. 264-276 13 p.

Research output: Research - peer-reviewArticle

Non-Small Cell Lung Carcinoma
Neoplasms
T-Lymphocytes
Mutation
Therapeutics

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

Brahmer, J. R., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., O'Brien, M., Rao, S., Hotta, K., Zhang, J., Lubiniecki, G. M., Deitz, A. C., Rangwala, R. & Reck, M. Dec 1 2017 In : The Lancet Oncology. 18, 12, p. 1600-1609 10 p.

Research output: Research - peer-reviewArticle

Non-Small Cell Lung Carcinoma
Cell Death
Quality of Life
Ligands
Drug Therapy